Medical Weight Loss for Charleston, South Carolina Residents
Charleston, South Carolina residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month, serving Charleston through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Charleston Residents Choose New Hope Weight Loss
Trust comes down to who is responsible and whether the price is straight, and on both counts New Hope gives Charleston a clear answer. Dr. Anjmun Sharma, MD personally oversees your care, the pricing is flat and posted, and the whole program reaches you by telehealth from Costa Mesa with no insurance required and no distance surcharge. A named physician, an honest number, and care that comes to you across South Carolina. That is the entire promise, and we keep it.
Charleston is served through telehealth from our Costa Mesa, California clinic. The full physician-supervised GLP-1 program runs by secure video, with compounded medication shipped to your Charleston address.
From the first visit to your refills, people in Charleston, South Carolina are cared for by Dr. Sharma through telehealth, so the only thing missing is the commute to Costa Mesa. We care for patients throughout Downtown and the Peninsula, West Ashley, Mount Pleasant, James Island, Daniel Island, and North Charleston. Because everything happens by telehealth, patients across Downtown and the Peninsula, West Ashley, Mount Pleasant, James Island, Daniel Island, and North Charleston get the same physician-led program without driving anywhere or sitting in a waiting room.
Your zip code inside South Carolina does not raise or lower the price, and it does not move you down a waitlist, because the whole program runs remotely. Your compounded semaglutide or tirzepatide ships directly to your Charleston address in an insulated cold-pack box, so it stays stable in transit. Across fast-growing South Carolina, New Hope Weight Loss treats patients entirely by telehealth from our Costa Mesa, California clinic, with no local office and no need to travel.
GLP-1 Weight Loss Programs Available
Begin your reset: semaglutide, from $166/mo
The 90-Day Metabolic Reset gives Charleston patients a structured three-month plan with semaglutide, the active ingredient shared with Wegovy and Ozempic. Choose $166 a month or $499 for the whole 90 days. In trials of the branded drug, the average was around 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary.
Go further: tirzepatide, from $233/mo
Tirzepatide hits both GLP-1 and GIP receptors for a dual effect. Qualifying doses in branded-drug trials reached up to 22.5 percent loss, which is not what most patients should expect. It carries the same active ingredient as Mounjaro and Zepbound.
Each plan begins with a $119 physician review. Medication is billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Charleston
Here is what to expect, step by step, from anywhere in Charleston.
Step 1. Fill out a quick intake quiz about your weight, health history, and goals.
Step 2. Dr. Anjmun Sharma reviews your intake and meets you by secure video, usually within 48 hours, to decide whether compounded semaglutide or tirzepatide is right for you.
Step 3. If she prescribes, a state-licensed 503(a) pharmacy ships your medication to your Charleston address in cold-pack packaging.
Step 4. You keep going with video follow-ups, no office visit required, anywhere in .
Frequently Asked Questions, Charleston
Does New Hope Weight Loss actually serve Charleston, or only Costa Mesa?
We serve both. Our single physical location sits in Costa Mesa, California, and we extend care to Charleston, South Carolina through telehealth. Residents across neighborhoods like Downtown and the Peninsula, West Ashley, Mount Pleasant, James Island, Daniel Island, and North Charleston qualify the same way. Dr. Anjmun Sharma evaluates whether a compounded GLP-1 plan fits you during your initial video appointment.
Can the whole process be done remotely from Charleston?
Yes, it is fully remote. There is no in-person requirement for Charleston patients at any stage. You meet Dr. Sharma over video, complete intake online, and receive ongoing support by message. Approved prescriptions arrive at your door in insulated cold-pack shipping that protects the medication during delivery.
How much will a Charleston patient pay?
Plan on $119 for the physician visit. Semaglutide runs from $166 monthly, with a $499 option for 90 days, and tirzepatide from $233 monthly. The medication cost is separate from the visit. HSA, FSA, Klarna, and Affirm are all welcome, and Charleston residents pay no added distance fee.
What areas of Charleston do you serve?
We serve patients from across Charleston by telehealth, including Downtown and the Peninsula, West Ashley, Mount Pleasant, James Island, Daniel Island, and North Charleston.
Is telehealth treatment as thorough as an in-person visit for Charleston patients?
Yes. Charleston patients get the same physician review by Dr. Sharma, the same contraindication screening, the same dose titration, and the same health-advisor support as any patient. Everything except a physical exam is handled by secure video, and compounded medication ships to your door. Telehealth eligibility is confirmed during the consultation.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Charleston, South Carolina by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.